Join Growin Stock Community!
Beta
Back to CLSK.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CLSK Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CLSK's operating expenses in Q2'26 shows SG&A expenses at $25.8M USD, with R&D expenses remaining at no data, resulting in total operating expenses of $25.8M USD for the quarter. Over the period from Q3'23 to Q2'26, SG&A expenses exhibited a clear upward trend, starting at $5.1M USD and more than quintupling to $25.8M USD, with notable acceleration in growth from Q3'25 onward, including a 67% quarter-over-quarter increase from Q1'26 to Q2'26. R&D expenses consistently showed no data across all quarters, indicating a focus on administrative and general costs as the primary driver of operating expenses in this stacked bar chart. This pattern suggests expanding operational scale, potentially tied to business growth, though the absence of R&D allocation warrants monitoring for future shifts.